Exome Asset Management LLC Portfolio Holdings

Exome Asset Management LLC

  • $146 Billion
  • Q3 2024

Exome Asset Management LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $146 Billion distributed in 56 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $9.26B, Ascendis Pharma A/S with a value of $6.55B, Bridge Bio Pharma, Inc. with a value of $5.37B, Structure Therapeutics Inc with a value of $5.27B, and Tg Therapeutics, Inc. with a value of $4.86B.

Examining the 13F form we can see an increase of $33.3B in the current position value, from $112B to 146B.

Exome Asset Management LLC is based out at New York, NY

Below you can find more details about Exome Asset Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $146 Billion
Healthcare: $131 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$756B
$9.26 Billion 6.35% of portfolio
10,447
Q3 2024 Added 7.7%
$7.75B
$6.55 Billion 4.5% of portfolio
43,849
Q3 2024 Added 119.25%
$4.23B
$5.37 Billion 3.69% of portfolio
211,000
Q3 2024 Added 167.4%
Structure Therapeutics Inc
-
$5.27 Billion 3.62% of portfolio
-
Q3 2024 New
$4.67B
$4.86 Billion 3.33% of portfolio
207,627
Q3 2024 Reduced 17.48%
$16.7B
$4.76 Billion 3.27% of portfolio
18,700
Q3 2024 New
$85.5B
$4.23 Billion 2.9% of portfolio
12,200
Q2 2024 Reduced 20.26%
$118B
$4.19 Billion 2.88% of portfolio
50,000
Q3 2024 New
$1.26B
$4.11 Billion 2.82% of portfolio
905,126
Q3 2024 New
$27.7B
$4.1 Billion 2.82% of portfolio
34,552
Q3 2024 New
$123B
$4.04 Billion 2.77% of portfolio
78,000
Q3 2024 New
$770M
$3.97 Billion 2.72% of portfolio
174,400
Q3 2024 New
$190B
$3.65 Billion 2.51% of portfolio
7,427
Q3 2024 Added 16.81%
$18.8B
$3.44 Billion 2.36% of portfolio
15,300
Q3 2024 Reduced 53.92%
$5.4B
$3.39 Billion 2.33% of portfolio
36,700
Q3 2024 New
$7.2B
$3.37 Billion 2.31% of portfolio
25,857
Q3 2024 New
Disc Medicine Inc
-
$3.17 Billion 2.18% of portfolio
-
Q3 2024 Added 5.76%
$4.57B
$3.09 Billion 2.12% of portfolio
58,583
Q3 2024 New
$509M
$2.94 Billion 2.02% of portfolio
414,629
Q3 2024 New
$1.87B
$2.94 Billion 2.02% of portfolio
66,200
Q3 2024 New
$3.66B
$2.89 Billion 1.99% of portfolio
100,367
Q3 2024 Added 114.0%
$2.6B
$2.88 Billion 1.98% of portfolio
36,300
Q2 2024 Reduced 57.79%
$15.7B
$2.85 Billion 1.96% of portfolio
22,450
Q3 2024 Added 20.38%
$21.5B
$2.57 Billion 1.77% of portfolio
13,317
Q3 2024 New
$9.56B
$2.45 Billion 1.68% of portfolio
33,600
Q3 2024 Reduced 40.85%
$5.49B
$2.29 Billion 1.57% of portfolio
47,000
Q3 2024 New
$365M
$2.22 Billion 1.53% of portfolio
300,600
Q3 2024 New
$157M
$2.23 Billion 1.53% of portfolio
1,178,570
Q3 2024 New
$1.59B
$2.21 Billion 1.52% of portfolio
138,152
Q3 2024 Reduced 49.74%
$1.33B
$2.21 Billion 1.52% of portfolio
77,100
Q3 2024 New
$446M
$2.17 Billion 1.49% of portfolio
176,600
Q3 2024 New
$141B
$2.16 Billion 1.48% of portfolio
6,700
Q3 2024 Reduced 43.22%
$3.23B
$2.06 Billion 1.41% of portfolio
89,800
Q3 2024 Added 13.67%
$3.55B
$2.04 Billion 1.4% of portfolio
19,945
Q3 2024 New
$212M
$1.8 Billion 1.24% of portfolio
347,600
Q3 2024 New
$593M
$1.76 Billion 1.21% of portfolio
90,305
Q3 2024 Reduced 31.45%
$171M
$1.71 Billion 1.17% of portfolio
352,056
Q3 2024 Added 24.67%
$657M
$1.68 Billion 1.15% of portfolio
149,600
Q3 2024 Added 20.65%
$1.87B
$1.6 Billion 1.1% of portfolio
59,900
Q3 2024 New
Karyopharm Therapeutics Inc
-
$1.52 Billion 1.04% of portfolio
-
Q3 2024 New
$1.2B
$1.52 Billion 1.04% of portfolio
40,800
Q3 2024 New
$1.44B
$1.5 Billion 1.03% of portfolio
45,600
Q3 2024 New
$1.43B
$1.49 Billion 1.03% of portfolio
196,500
Q3 2024 New
$2.35B
$1.12 Billion 0.77% of portfolio
133,039
Q3 2024 New
Tectonic Therapeutic Inc
-
$1.1 Billion 0.76% of portfolio
-
Q3 2024 Added 12.21%
$389M
$953 Million 0.65% of portfolio
73,501
Q3 2024 Added 23.22%
-
$817 Million 0.56% of portfolio
-
Q3 2024 New
Lexeo Therapeutics Inc
-
$797 Million 0.55% of portfolio
-
Q3 2024 New
Vyne Therapeutics Inc
-
$664 Million 0.46% of portfolio
-
Q2 2024 Reduced 14.92%

Summary

  • Portfolio
  • No. of Stocks 56
  • Current Value $146 Billion
  • Prior Value $112 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 30 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email